AGP
Artia Global Partners Portfolio holdings
AUM
$389M
This Quarter Return
+4.92%
1 Year Return
+34.68%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$390M
AUM Growth
+$390M
(-4.4%)
Cap. Flow
-$27.1M
Cap. Flow
% of AUM
-6.96%
Top 10 Holdings %
Top 10 Hldgs %
82.6%
Holding
55
New
7
Increased
8
Reduced
8
Closed
12
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$8.51M |
| 2 |
Merck
MRK
|
$7.84M |
| 3 |
Ionis Pharmaceuticals
IONS
|
$2.98M |
| 4 |
Celldex Therapeutics
CLDX
|
$2.79M |
| 5 |
Soleno Therapeutics
SLNO
|
$2.18M |
Top Sells
| 1 |
AbbVie
ABBV
|
$16.5M |
| 2 |
argenx
ARGX
|
$8.21M |
| 3 |
Cytokinetics
CYTK
|
$6.28M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$4.69M |
| 5 |
Insmed
INSM
|
$4.34M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vera Therapeutics
VERA
$1.42B
| – | – |
-24,298
| Closed | -$1.05M |
|
|
PSTX
52
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| – | – |
-86,002
| Closed | -$274K |
|
|
GRTS
53
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| – | – |
-95,170
| Closed | -$245K |
|
|
EFTR
54
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| – | – |
0
| – | – |
|
|
ALPN
55
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – |
-51,714
| Closed | -$2.05M |
|